![Erik Domines](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Erik Domines worked as the General Counsel at Recipharm AB from 2014 to 2018 and at Xbrane Biopharma AB from 2021 to 2023.
He completed his undergraduate degree at the University of Stockholm.
Precedenti posizioni note di Erik Domines
| Società | Posizione | Fine |
|---|---|---|
| XBRANE BIOPHARMA AB | Consigliere Generale | 01/07/2023 |
| RECIPHARM AB (PUBL) | Consigliere Generale | 31/12/2018 |
Formazione di Erik Domines
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Recipharm AB
 Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xbrane Biopharma AB
 Xbrane Biopharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilars for s eye diseases | Health Technology |
